0001104659-21-116924.txt : 20210917
0001104659-21-116924.hdr.sgml : 20210917
20210917161713
ACCESSION NUMBER: 0001104659-21-116924
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210819
FILED AS OF DATE: 20210917
DATE AS OF CHANGE: 20210917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PRENDERGAST FRANKLYN G
CENTRAL INDEX KEY: 0001233256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35963
FILM NUMBER: 211260624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuBase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001173281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465622433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 700 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
BUSINESS PHONE: 6464501790
MAIL ADDRESS:
STREET 1: 700 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
FORMER COMPANY:
FORMER CONFORMED NAME: Ohr Pharmaceutical Inc
DATE OF NAME CHANGE: 20090819
FORMER COMPANY:
FORMER CONFORMED NAME: BBM HOLDINGS, INC.
DATE OF NAME CHANGE: 20070402
FORMER COMPANY:
FORMER CONFORMED NAME: PRIME RESOURCE INC
DATE OF NAME CHANGE: 20020513
4
1
tm2127926-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-08-19
0
0001173281
NeuBase Therapeutics, Inc.
NBSE
0001233256
PRENDERGAST FRANKLYN G
C/O 350 TECHNOLOGY DRIVE, FOURTH FLOOR
PITTSBURGH
PA
15219
1
0
0
0
Stock option (right to buy)
3.36
2021-08-19
4
A
0
38135
0
A
2031-08-19
Common Stock
38135
38135
D
25% of the total shares shall vest on the first anniversary of August 19, 2021, and the remaining shares shall vest on an equal monthly basis over the following 36 months.
The power of attorney under which this form was signed is on file with the Commission.
/s/ Sam Backenroth, as attorney-in-fact for Franklyn G. Prendergast
2021-09-17